Novel antibiotic candidates
Our invention is a series of small chemical molecules proven effective to kill bacterial pathogens. These molecules have new antimicrobial mechanism and high potential as novel antibiotic drug candidates.
Unmet Need
- Infections caused by antibiotic-resistant bacteria are a major cause of death, burdening healthcare systems across the world.
- No new classes of antibiotics were discovered in the past 40 years, culminating in a global public health crisis.
Our Solution
- Established an AI-based platform to enhance the discovery and development of novel drugs combatting infectious diseases.
- This enables for increases in success rates, streamlines the discovery process, and significantly reduces costs in drug R&D.
- Invented first-in-class antibiotic drug candidates with new targets, new modes-of-action, and new chemical structures, which can effectively kill resistant bacteria with low chance of inducing drug resistance and were proven safe and effective in animal models.
